Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 8/20 | 0.56 |
| ▸ | CSNK1A1 | P48729 | 2/20 | 0.56 |
| ▸ | IKZF1 | Q13422 | 2/20 | 0.53 |
| ▸ | IKZF2 | Q9UKS7 | 10/20 | 0.51 |
| ▸ | GSPT1 | P15170 | 2/20 | 0.48 |
| ▸ | DDB1 | Q16531 | 2/20 | 0.48 |
| ▸ | IKZF3 | Q9UKT9 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23358009 | 1.00 | CRBN (0.56) | CRBNCSNK1A1IKZF1IKZF2GSPT1 | |
| SCHEMBL23357980 | 0.92 | CRBN (0.51) | CRBNCSNK1A1IKZF1IKZF2GSPT1 | |
| SCHEMBL29944409 | 0.92 | IKZF2 (0.60) | CRBNCSNK1A1IKZF1IKZF2GSPT1 | |
| SCHEMBL23357936 | 0.92 | IKZF2 (0.60) | CRBNCSNK1A1IKZF1IKZF2GSPT1 | |
| SCHEMBL29944515 | 0.89 | IKZF2 (0.55) | CRBNCSNK1A1IKZF1IKZF2GSPT1 | |
| SCHEMBL23358078 | 0.89 | IKZF2 (0.55) | CRBNCSNK1A1IKZF1IKZF2GSPT1 | |
| SCHEMBL29944362 | 0.89 | IKZF2 (0.49) | CRBNCSNK1A1IKZF1IKZF2GSPT1 | |
| SCHEMBL23357954 | 0.89 | IKZF2 (0.49) | CRBNCSNK1A1IKZF1IKZF2GSPT1 | |
| SCHEMBL23357940 | 0.88 | IKZF2 (0.54) | CRBNCSNK1A1IKZF1IKZF2GSPT1 | |
| SCHEMBL29944385 | 0.88 | IKZF2 (0.54) | CRBNCSNK1A1IKZF1IKZF2GSPT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4061812-B1 | COMPOUNDS USEFUL AS INHIBITORS OF HELIOS PROTEIN | BRISTOL MYERS SQUIBB CO (US) | 2026-03-25 | — | — | EP | claimed |
| EP-4061812-A1 | COMPOUNDS USEFUL AS INHIBITORS OF HELIOS PROTEIN | Bristol-Myers Squibb Company (US) | 2022-09-28 | — | — | EP | claimed |
| EP-4061812-B1 | COMPOUNDS USEFUL AS INHIBITORS OF HELIOS PROTEIN | BRISTOL MYERS SQUIBB CO (US) | 2026-03-25 | — | — | EP | disclosed |
| EP-4061812-A1 | COMPOUNDS USEFUL AS INHIBITORS OF HELIOS PROTEIN | Bristol-Myers Squibb Company (US) | 2022-09-28 | — | — | EP | disclosed |